انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
Survival Outcomes of Patients with Clinical Stage III Melanoma in the Era of Novel Systemic Therapies
Manage episode 296721470 series 2947447
Rick Greene, MD and Giorgos Karakousis, MD discuss the impact of immune checkpoint and BRAF/MEK pathway inhibitors on outcomes and melanoma care at a national population level in patients diagnosed with clinical stage III melanoma. Dr. Karakousis is author of, “Survival Outcomes of Patients with Clinical Stage III Melanoma in the Era of Novel Systemic Therapies.”
Dr. Karakousis is Associate Professor of Surgery at the Hospital of the University of Pennsylvania, Philadelphia, PA.
59 حلقات
Manage episode 296721470 series 2947447
Rick Greene, MD and Giorgos Karakousis, MD discuss the impact of immune checkpoint and BRAF/MEK pathway inhibitors on outcomes and melanoma care at a national population level in patients diagnosed with clinical stage III melanoma. Dr. Karakousis is author of, “Survival Outcomes of Patients with Clinical Stage III Melanoma in the Era of Novel Systemic Therapies.”
Dr. Karakousis is Associate Professor of Surgery at the Hospital of the University of Pennsylvania, Philadelphia, PA.
59 حلقات
すべてのエピソード
×مرحبًا بك في مشغل أف ام!
يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.